MULTICARE PHARMACEUTICALS — Febuxostat Importer Profile
Pharmaceutical Importer · #3 buyer for Febuxostat · $1.4M import value · 28 shipments · PHILIPPINES · DGFT Verified
MULTICARE PHARMACEUTICALS is the #3 importer of Febuxostat from India with $1.4M in import value and 28 verified shipments. MULTICARE PHARMACEUTICALS holds a 2.0% market share in Febuxostat imports based in PHILIPPINES. The company sources from 1 verified supplier across 19 formulations shipped to 1 country. Overall, MULTICARE PHARMACEUTICALS imports 2 pharmaceutical products worth $1.0M across 2 therapeutic categories.
MULTICARE PHARMACEUTICALS — Febuxostat Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Febuxostat to MULTICARE PHARMACEUTICALS?
Verified from 28 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LUPIN LIMITED | $1.4M | 28 | 100.0% |
MULTICARE PHARMACEUTICALS sources Febuxostat from 1 verified Indian supplier based on 28 customs records. The primary supplier is LUPIN LIMITED accounting for 100.0% of imports.
How Does MULTICARE PHARMACEUTICALS Compare to Nearest Febuxostat Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $1.3M | 25 | $50.0K |
| 4 | J. KNIPPER & COMPANY, | UNITED STATES | $1.1M | 22 | $50.0K |
| 3 | MULTICARE PHARMACEUTICALS ★ | PHILIPPINES | $1.0M | 20 | $50.0K |
| 5 | J KNIPPER COMPANY | UNITED STATES | $1.0M | 20 | $50.0K |
| 7 | MARCAN PHARMACEUTICALS INC | CANADA | $600.0K | 12 | $50.0K |
MULTICARE PHARMACEUTICALS ranks #3 among 421 Febuxostat importers from India. Average shipment value of $50.0K compared to the market average of $26.8K. The closest competitors by value are AJANTA PHARMA PHILIPPINES INC and J. KNIPPER & COMPANY,.
Where Does MULTICARE PHARMACEUTICALS Import Febuxostat To?
Destination countries from 28 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.4M | 28 | 100.0% |
MULTICARE PHARMACEUTICALS imports Febuxostat to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $1.4M.
What Febuxostat Formulations Does MULTICARE PHARMACEUTICALS Import?
| Formulation | Value | Shipments |
|---|---|---|
| FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | $200.0K | 4 |
| FURIC 40 10X10 FEBUXOSTAT TABLETS 40MG O | $150.0K | 3 |
| FURIC 40-10X10T(EXPORT)(FEBUXOSTAT TABS40MG)BT#JA00915 TO JA00924,MFG#04.2024,EXP#03.2026(OTHERS-MEDICINE PUT UP FOR RE | $150.0K | 3 |
| FURIC 80 10X10 FEBUXOSTAT TABLETS 80MG B | $100.0K | 2 |
| Furic 80 - 10 x 10T (Export) FebuxostatTablets 80 mg Others-Medicine Put Up ForRetail Sale | $100.0K | 2 |
| FURIC 80-10X10 FEBUXOSTAT TABLETS 80MG O | $50.0K | 1 |
| FURIC 40-10X10 FEBUXOSTAT TABLETS 40MG O | $50.0K | 1 |
| FURIC 80 10X10T FEBUXOSTAT TABLETS 80MG | $50.0K | 1 |
| FURIC 40-10 X10T (EXPORT)FEBUXOSTAT TABL | $50.0K | 1 |
| FURIC 40 10X10 FEBUXOSTAT TABLETS 40MG | $50.0K | 1 |
MULTICARE PHARMACEUTICALS imports 19 distinct Febuxostat formulations from India. The top formulation is FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG with 4 shipments worth $200.0K.
Who Are the Top Buyers of Febuxostat from India and How Much Does MULTICARE PHARMACEUTICALS Import?
India exported $11.3M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. MULTICARE PHARMACEUTICALS imports $1.4M of this total, accounting for 2.0% of India's Febuxostat exports with 28 shipments from PHILIPPINES. This is verified from 28 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for MULTICARE PHARMACEUTICALS's Febuxostat Imports?
MULTICARE PHARMACEUTICALS's average Febuxostat order value is $50.0K per consignment, based on 28 shipments totaling $1.4M. MULTICARE PHARMACEUTICALS is based in PHILIPPINES and ranks #3 among all Febuxostat importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Febuxostat to MULTICARE PHARMACEUTICALS?
MULTICARE PHARMACEUTICALS sources Febuxostat from 1 verified Indian supplier: LUPIN LIMITED ($1.4M, 100.0%). This is based on 28 customs records.
How Does MULTICARE PHARMACEUTICALS Compare to Other Febuxostat Importers?
MULTICARE PHARMACEUTICALS ranks #3 among 421 Febuxostat importers from India with a 2.0% market share. The top 3 importers are UNILAB INC ($1.9M), AJANTA PHARMA PHILIPPINES INC ($1.3M), J. KNIPPER & COMPANY, ($1.1M). MULTICARE PHARMACEUTICALS processed 28 shipments from PHILIPPINES.
About MULTICARE PHARMACEUTICALS
MULTICARE PHARMACEUTICALS imports 2 products worth $1.0M. Beyond Febuxostat, top products include Dacarbazine. View the complete MULTICARE PHARMACEUTICALS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MULTICARE PHARMACEUTICALS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MULTICARE PHARMACEUTICALS's capped import value divided by total capped export value for Febuxostat across all Indian exporters.
- 5.Verified Records: This page is backed by 28 individual customs records matching MULTICARE PHARMACEUTICALS importing Febuxostat, covering 19 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Import Data for MULTICARE PHARMACEUTICALS
Access order-level details, pricing data, supplier connections, and competitive analysis for MULTICARE PHARMACEUTICALS's Febuxostat imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MULTICARE PHARMACEUTICALS
Full Company Profile →
2 products · $1.0M total trade · 2 categories
MULTICARE PHARMACEUTICALS × Febuxostat
Verified from customs records
Company Overview
Top Products by MULTICARE PHARMACEUTICALS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MULTICARE PHARMACEUTICALS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current order-level data, contact TransData Nexus.